Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...

Gullapalli will oversee the Amgen India Technology and Innovation hub, leveraging his extensive expertise in global ...

Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

The most recent trading session ended with Amgen (AMGN) standing at $273.41, reflecting a -0.85% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which registered a ...

The Holywood golfer registered nine top tens on last season’s Race to Dubai, including a runner-up finish in Italy, while he ...

Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...

Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today. The company’s shares closed ...

SHANE LOWRY has been confirmed for the 2025 Irish Open – declaring that home fans are “the best in the world”. The 2025 ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...